178 related articles for article (PubMed ID: 30203148)
1. Variability in HER2 expression between primary colorectal cancer and corresponding metastases.
Shan L; Lv Y; Bai B; Huang X; Zhu H
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2275-2281. PubMed ID: 30203148
[TBL] [Abstract][Full Text] [Related]
2. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
3. HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2015 Apr; 54(4):480-6. PubMed ID: 25601452
[TBL] [Abstract][Full Text] [Related]
4. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
5. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
6. The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases.
Stenstedt K; Hallstrom M; Lédel F; Ragnhammar P; Ingelman-Sundberg M; Johansson I; Edler D
Acta Oncol; 2014 Jul; 53(7):885-91. PubMed ID: 24625228
[TBL] [Abstract][Full Text] [Related]
7. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and diagnostic accuracy of HER2 immunohistochemistry in colorectal cancer: a meta-analysis.
Pyo JS; Kang G; Park K
Int J Biol Markers; 2016 Dec; 31(4):e389-e394. PubMed ID: 27102863
[TBL] [Abstract][Full Text] [Related]
10. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
11. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
[TBL] [Abstract][Full Text] [Related]
12. HER2 expression variability between primary gastric cancers and corresponding lymph node metastases.
Qiu Z; Sun W; Zhou C; Zhang J
Hepatogastroenterology; 2015; 62(137):231-3. PubMed ID: 25911901
[TBL] [Abstract][Full Text] [Related]
13. HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides.
Wei Q; Xu J; Shen L; Fu X; Zhang B; Zhou X; Carlsson J
Tumour Biol; 2014 Jul; 35(7):6319-26. PubMed ID: 24643685
[TBL] [Abstract][Full Text] [Related]
14. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
Wei Q; Shui Y; Zheng S; Wester K; Nordgren H; Nygren P; Glimelius B; Carlsson J
Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
[TBL] [Abstract][Full Text] [Related]
15. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
Falck AK; Fernö M; Bendahl PO; Rydén L
World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases.
Lee WS; Park YH; Lee JN; Baek JH; Lee TH; Ha SY
Cancer Med; 2014 Jun; 3(3):674-80. PubMed ID: 24668895
[TBL] [Abstract][Full Text] [Related]
17. Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases.
Desouki MM; Atta IS; Wolff DJ; Self SE
Turk Patoloji Derg; 2016; 32(3):178-85. PubMed ID: 27562392
[TBL] [Abstract][Full Text] [Related]
18. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer.
Zhao S; Xu L; Liu W; Lv C; Zhang K; Gao H; Wang J; Ma R
Int J Clin Exp Pathol; 2015; 8(5):5744-8. PubMed ID: 26191291
[TBL] [Abstract][Full Text] [Related]
20. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.
Ye P; Li F; Wei Y; Zhang Y; Cui J; Dai R; Chen H; Xie J; Cai P
Sci Rep; 2022 Jul; 12(1):12894. PubMed ID: 35902718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]